Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-27

Clinical Trial Update: Olanzapine Versus Placebo for Moderately Emetogenic Chemotherapy [Phase 3]

View source ↗

Summary

This Phase 3 trial compares olanzapine to placebo for preventing chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemothera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olanzapine (olanzapine)

Snippet

Sponsor: Mahidol University | Conditions: Chemotherapy Induced Nausea and Vomiting | Phase 3 | Status: RECRUITING